Literature DB >> 8051147

Topology of the Glut 1 glucose transporter deduced from glycosylation scanning mutagenesis.

R C Hresko1, M Kruse, M Strube, M Mueckler.   

Abstract

The erythrocyte glucose transporter (Glut 1) is predicted to contain 12 membrane-spanning domains based on the hydropathy plot of its deduced amino acid sequence. The membrane topology of Glut 1 was analyzed by a scanning mutagenesis procedure in which the glycosylated exofacial domain of Glut 4 was inserted independently into each of the putative hydrophilic soluble domains of an aglyco-Glut 1 construct. The transporter mutants were expressed both in vitro using a rabbit reticulocyte lysate translation system and in vivo in Xenopus oocytes. The cytoplasmic or exofacial orientation of each soluble domain was inferred from the glycosylation state of the corresponding insertion mutant. The results from the cell-free system were aberrant in that two topological orientations were observed when the epitope was inserted into any of the short cytoplasmic loops or the NH2 terminus. The in vivo data, however, were in complete agreement with the proposed 12-helix model. Therefore, the multiple topologies observed in vitro probably resulted from the inability of the cell-free system to facilitate the proper folding of the insertion mutants into the membrane. 2-Deoxyglucose uptake data on the glycosylation mutants indicated that epitope insertion into the NH2 terminus, the large central loop, or the second, third, or fifth exofacial loop had no dramatic effect on the activity of the transporter. However, insertion into the other soluble domains either completely abolished or significantly reduced transport activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051147

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Topology studies with biosynthetic fragments identify interacting transmembrane regions of the human red-cell anion exchanger (band 3; AE1).

Authors:  J D Groves; M J Tanner
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 2.  Membrane topology and insertion of membrane proteins: search for topogenic signals.

Authors:  M van Geest; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 3.  Kinetoplastid glucose transporters.

Authors:  E Tetaud; M P Barrett; F Bringaud; T Baltz
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

4.  Transmembrane topology of a CLC chloride channel.

Authors:  T Schmidt-Rose; T J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 5.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

6.  Proposed structure of putative glucose channel in GLUT1 facilitative glucose transporter.

Authors:  H Zeng; R Parthasarathy; A L Rampal; C Y Jung
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

7.  Possible domains responsible for intracellular targeting and insulin-dependent translocation of glucose transporter type 4.

Authors:  K Ishii; H Hayashi; M Todaka; S Kamohara; F Kanai; H Jinnouchi; L Wang; Y Ebina
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

8.  Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants.

Authors:  Juan M Pascual; Dong Wang; Ru Yang; Lei Shi; Hong Yang; Darryl C De Vivo
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

9.  Model of the exofacial substrate-binding site and helical folding of the human Glut1 glucose transporter based on scanning mutagenesis.

Authors:  Mike Mueckler; Carol Makepeace
Journal:  Biochemistry       Date:  2009-06-30       Impact factor: 3.162

10.  Analysis of glucose transporter topology and structural dynamics.

Authors:  David M Blodgett; Christopher Graybill; Anthony Carruthers
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.